ArticleCell communication and signaling : CCS2022

BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death.

Huey-Jiun Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.